KalVista Pharmaceuticals Current Ratio 2014-2020 | KALV

KalVista Pharmaceuticals current ratio from 2014 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
KalVista Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-10-31 $0.07B $0.01B 7.56
2020-07-31 $0.08B $0.01B 9.49
2020-04-30 $0.09B $0.01B 11.49
2020-01-31 $0.10B $0.01B 10.14
2019-10-31 $0.11B $0.01B 10.31
2019-07-31 $0.12B $0.01B 8.29
2019-04-30 $0.12B $0.02B 6.40
2019-01-31 $0.12B $0.02B 6.59
2018-10-31 $0.13B $0.02B 6.21
2018-07-31 $0.06B $0.02B 2.41
2018-04-30 $0.06B $0.02B 2.56
2018-01-31 $0.07B $0.02B 2.73
2017-10-31 $0.03B $0.00B 9.72
2017-07-31 $0.03B $0.00B 7.87
2017-04-30 $0.03B $0.00B 11.33
2017-01-31 $0.04B $0.00B 11.86
2016-10-31 $0.00B 0.00
2016-09-30 $0.04B $0.00B 18.94
2016-07-31 $0.00B 0.00
2016-06-30 $0.04B $0.00B 19.68
2016-04-30 $0.03B $0.00B 7.59
2016-03-31 $0.05B $0.00B 12.84
2016-01-31 $0.00B 0.00
2015-12-31 $0.06B $0.00B 12.87
2015-09-30 $0.06B $0.00B 16.20
2015-06-30 $0.07B $0.00B 16.08
2015-04-30 $0.00B 0.00
2015-03-31 $0.00B $0.01B 0.39
2015-01-31 $0.00B $0.00B 34.50
2014-12-31 $0.01B $0.01B 0.65
2014-10-31 $0.01B $0.01B 0.65
2014-09-30 $0.00B 0.00
2014-07-31 $0.00B 0.00
2014-06-30 $0.00B 0.00
2014-04-30 $0.00B 0.00
2014-03-31 $0.00B 0.00
2014-01-31 $0.01B $0.00B 2.51
2013-01-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.295B $0.013B
KalVista Pharmaceuticals, Inc. is a pharmaceuticals company. It engages in discovery, development and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product portfolio consist hereditary angioedema and diabetic macular edema, KVD818 and KVD001, which are in clinical stage. KalVista Pharmaceuticals, Inc., formerly known as Carbylan Therapeutics, Inc., is headquartered in Cambridge, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.680B 41.80
Takeda Pharmaceutical (TAK) Japan $57.916B 10.81
Astellas Pharma (ALPMY) Japan $30.701B 19.17
Eisai (ESALY) Japan $22.474B 19.58
Merck (MKGAF) Germany $22.165B 0.00
UCB SA (UCBJF) Belgium $20.763B 0.00
Catalent (CTLT) United States $19.060B 57.01
Grifols, S.A (GRFS) Spain $13.050B 14.94
Neurocrine Biosciences (NBIX) United States $11.155B 87.79
Jazz Pharmaceuticals (JAZZ) Ireland $9.526B 15.39
Ionis Pharmaceuticals (IONS) United States $8.918B 87.37
Arrowhead Pharmaceuticals (ARWR) United States $8.645B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.532B 0.00
United Therapeutics (UTHR) United States $7.526B 16.02
IPSEN SA ADR (IPSEY) France $7.292B 0.00
STADA ARZNEIMI (STDAF) Germany $6.884B 0.00
Orion OYJ (ORINY) Finland $6.427B 22.30
Evotec AG (EVTCY) Germany $5.923B 401.50
Sage Therapeutics (SAGE) United States $4.708B 0.00
FibroGen (FGEN) United States $4.513B 0.00
ChemoCentryx (CCXI) United States $4.486B 0.00
PTC Therapeutics (PTCT) United States $4.334B 0.00
Hypermarcas (HYPMY) Brazil $4.187B 16.52
Cronos Group (CRON) Canada $3.526B 0.00
Corcept Therapeutics (CORT) United States $3.318B 32.09
Nektar Therapeutics (NKTR) United States $3.183B 0.00
Pacira BioSciences (PCRX) United States $3.032B 65.85
Taro Pharmaceutical Industries (TARO) Israel $2.938B 15.00
Revolution Medicines (RVMD) United States $2.861B 0.00
Xencor (XNCR) United States $2.796B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.371B 0.00
Tilray (TLRY) Canada $2.295B 0.00
USANA Health Sciences (USNA) United States $1.884B 16.58
Translate Bio (TBIO) United States $1.831B 0.00
Endo (ENDP) Ireland $1.677B 2.55
Ironwood Pharmaceuticals (IRWD) United States $1.671B 14.30
Heron Therapeutics (HRTX) United States $1.661B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.617B 0.00
Ocular Therapeutix (OCUL) United States $1.580B 0.00
ImmunoGen (IMGN) United States $1.505B 0.00
Indivior (INVVY) United States $1.467B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.454B 10.10
Trillium Therapeutics (TRIL) Canada $1.324B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.178B 0.00
Karyopharm Therapeutics (KPTI) United States $1.156B 0.00
Organogenesis Holdings (ORGO) United States $1.122B 0.00
VAXART, INC (VXRT) United States $1.100B 0.00
Zogenix (ZGNX) United States $1.092B 0.00
Radius Health (RDUS) United States $0.990B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.967B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
Aerie Pharmaceuticals (AERI) United States $0.853B 0.00
Collegium Pharmaceutical (COLL) United States $0.846B 49.92
Esperion Therapeutics (ESPR) United States $0.803B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.770B 0.00
Aclaris Therapeutics (ACRS) United States $0.757B 0.00
Acutus Medical (AFIB) United States $0.732B 0.00
Ardelyx (ARDX) United States $0.694B 0.00
Chinook Therapeutics (KDNY) United States $0.679B 0.00
Sundial Growers (SNDL) Canada $0.665B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.622B 0.00
Flexion Therapeutics (FLXN) United States $0.603B 0.00
Molecular Templates (MTEM) United States $0.597B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.572B 0.00
Altimmune (ALT) United States $0.559B 0.00
Akebia Therapeutics (AKBA) United States $0.536B 0.00
Siga Technologies (SIGA) United States $0.532B 14.94
Harpoon Therapeutics (HARP) United States $0.531B 0.00
Jounce Therapeutics (JNCE) United States $0.524B 0.00
PROFOUND MEDICL (PROF) Canada $0.524B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.502B 0.00
Summit Therapeutics (SMMT) United States $0.497B 0.00
DURECT (DRRX) United States $0.486B 0.00
TherapeuticsMD (TXMD) United States $0.483B 0.00
Menlo Therapeutics (VYNE) United States $0.443B 0.00
CASI Pharmaceuticals (CASI) United States $0.429B 0.00
Rafael Holdings (RFL) United States $0.402B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.397B 0.00
Jaguar Animal Health (JAGX) United States $0.392B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.385B 10.03
Innate Pharma SA (IPHYF) France $0.371B 0.00
MEI Pharma (MEIP) United States $0.343B 0.00
Concert Pharmaceuticals (CNCE) United States $0.341B 0.00
Lannett Co Inc (LCI) United States $0.331B 8.71
Matinas Biopharma Holdings (MTNB) United States $0.327B 0.00
Nature's Sunshine Products (NATR) United States $0.314B 20.19
Alpine Immune Sciences (ALPN) United States $0.303B 0.00
Redhill Biopharma (RDHL) Israel $0.296B 0.00
Xeris Pharmaceuticals (XERS) United States $0.274B 0.00
CTI BioPharma (CTIC) United States $0.254B 0.00
Infinity Pharmaceuticals (INFI) United States $0.254B 0.00
IMV INC (IMV) Canada $0.242B 0.00
Otonomy (OTIC) United States $0.233B 0.00
OptiNose (OPTN) United States $0.232B 0.00
Calithera Biosciences (CALA) United States $0.226B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.218B 0.00
Oncternal Therapeutics (ONCT) United States $0.213B 0.00
Taiwan Liposome (TLC) Taiwan $0.192B 0.00
IsoRay (ISR) United States $0.192B 0.00
Novan (NOVN) United States $0.191B 0.00
Aquestive Therapeutics (AQST) United States $0.190B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.188B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.184B 0.00
Heat Biologics (HTBX) United States $0.183B 0.00
ProPhase Labs (PRPH) United States $0.182B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.170B 0.00
Champions Oncology (CSBR) United States $0.162B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.155B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.155B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.153B 0.00
Lipocine (LPCN) United States $0.145B 0.00
Onconova Therapeutics (ONTX) United States $0.142B 0.00
MediWound (MDWD) Israel $0.139B 0.00
ElectroCore (ECOR) United States $0.125B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.122B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.116B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.098B 0.00
Nutriband (NTRB) United States $0.092B 0.00
Iterum Therapeutics (ITRM) Ireland $0.089B 0.00
Hemispherx BioPharma (AIM) United States $0.089B 0.00
Biomerica (BMRA) United States $0.088B 0.00
KemPharm (KMPH) United States $0.088B 0.00
Natural Alternatives (NAII) United States $0.086B 165.37
SCYNEXIS (SCYX) United States $0.084B 0.00
Recro Pharma (REPH) United States $0.083B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.081B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.074B 0.00
AgeX Therapeutics (AGE) United States $0.073B 0.00
Vical (BBI) United States $0.069B 0.00
CV Sciences (CVSI) United States $0.066B 0.00
India Globalization Capital (IGC) United States $0.064B 0.00
Addex Therapeutics (ADXN) Switzerland $0.064B 0.00
PolarityTE (PTE) United States $0.061B 0.00
Trimel Pharmaceuticals (ASPCF) Canada $0.057B 0.00
RENEURON GP (RNUGF) United Kingdom $0.057B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.053B 0.00
Regulus Therapeutics (RGLS) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 25.39
Neos Therapeutics (NEOS) United States $0.044B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.043B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.040B 5.88
Can-Fite Biopharma (CANF) Israel $0.032B 0.00
Midatech Pharma (MTP) United Kingdom $0.031B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.031B 0.00
Flex Pharma (SLRX) United States $0.031B 0.00
China SXT Pharmaceuticals (SXTC) China $0.022B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.022B 0.00
Cyanotech (CYAN) United States $0.021B 33.95
HANCOCK JAFFE (HJLI) United States $0.020B 0.00
Xenetic Biosciences (XBIO) United States $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
RXi Pharmaceuticals (PHIO) United States $0.017B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.015B 0.00
SHINECO INC (TYHT) China $0.011B 0.00
JanOne (JAN) United States $0.010B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00